Plasma homocyst(e)ine concentrations in pregnant and nonpregnant women with controlled folate intake

Obstetrics and Gynecology

Volumn 92, Issue 2, 1998, Pages 167-170

  Bonnette, Richard E ^a   Caudill, Marie A ^a   Boddie, Anita M ^a   Hutson, Alan D ^a   Kauwell, Gail P A ^a   Bailey, Lynn B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLATE METABOLISM; HOMOCYSTINURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; NUTRITIONAL REQUIREMENT; PRIORITY JOURNAL; PROTEIN BINDING; SECOND TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, SECOND;

EID: 0032146822     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00154-9     Document Type: Article

References (21)

1. 1. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem 1990;1:228-37.
2. 2. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994;96:239-46.
3. 3. O'Keefe CA, Bailey LB, Thomas EA, Hofler SA, Davis BA, Cerda JJ, et al. Controlled dietary folate affects folate status in nonpregnant women. J Nutr 1995;125:2717-25.
4. 4. Lindenbaum J, Allen RH. Clinical spectrum and diagnosis of folate deficiency. In: Bailey LB, ed. Folate in health and disease. New York: Marcel Dekker, 1995:43-73.
5. 5. Rajkovic A, Catalano PM, Malinow MR. Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol 1997;90:168-71.
6. 6. Goddijn-Wessel TA, Wouters MG, van de Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, et al. Hyperhomocysteinemia: A risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996;66:23-9.
7. 7. Wouters MGAJ, Boers GHJ, Blom HJ, Trijbels FJM, Thomas CMG, Borm GF, et al. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820-5.
8. 8. Burke G, Robinson K, Refsum H, Stuart B, Drumm J, Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med 1992;326:69-70.
9. 9. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Finklestein JD, Blom HJ, Thomas CMG, et al. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects? Metabolism 1994;43:1475-80.
10. 10. Food and Nutrition Board. Recommended Dietary Allowances. Washington, DC: National Academy Press, 1989.
11. 11. Food and Nutrition Board. Recommended Dietary Allowances. Washington, DC: National Academy Press, 1980.
12. 12. Caudill MA, Cruz AC, Gregory JF, Hutson AD, Bailey LB. Folate status response to controlled folate intake in pregnant women. J Nutr 1997;127:2363-70.
13. 13. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma and serum: Methods and clinical applications. Clin Chem 1993;39:1764-79.
14. 14. Andersson A, Hultberg B, Brattstrom L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 1992;30:377-9.
15. 15. Kang SS, Wong PWK, Zhou J, Cook HC. Total homocysteine in plasma and amniotic fluid of pregnant women. Metabolism 1986; 35:889-91.
16. 16. Steegers-Theunissen RPM, Wathen NC, Eskes TKA, van Raaij-Selten B, Chard T. Maternal and fetal levels of methionine and homocysteine in early human pregnancy. Br J Obstet Gynaecol 1997;104:20-4.
17. 17. Blackburn ST, Loper DL. The hematologic and hemostatic systems. In: Eoyang T, ed. Maternal, fetal, and neonatal physiology. Philadelphia: WB Saunders, 1992:159-200.
18. 18. Cetin I, Ronzoni S, Marconi AM, Perugino G, Corbetta C, Battaglia FC, et al. Maternal concentrations and fetal-maternal concentration differences of plasma amino acids in normal and intrauterine growth-restricted pregnancies. Am J Obstet Gynecol 1996;174: 1575-83.
19. 19. Lauritzen C, Klopper A. Estrogens and androgens. In: Fuchs F, ed. Endocrinology of pregnancy. Philadelphia: Harper & Row, 1983: 73-89.
20. 20. Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Schellekens LA, Thomas CM, et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25:801-5.
21. 21. van der Mooren MJ, Demacker PNM, Blom HJ, de Rijke YB, Rolland R. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women. Fertil Steril 1997;67:67-73.